17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of novel inverse agonists of estrogen-related receptors ERR¿ and ERRß.

The Beckman Research Institute
Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists.

Daegu-Gyeongbuk Medical Innovation Foundation
1-Benzyl-4-phenyl-1H-1,2,3-triazoles improve the transcriptional functions of estrogen-related receptor¿ and promote the browning of white adipose.

Guangzhou Institutes of Biomedicine and Health
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORß and ROR¿t.

Phenex Pharmaceuticals
Identification of diaryl ether-based ligands for estrogen-related receptora as potential antidiabetic agents.

Johnson & Johnson Pharmaceutical Research and Development
Structure-based discovery of pyrazolamides as novel ERRγ inverse agonists.

Chonnam National University
An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer.

Daegu-Gyeongbuk Medical Innovation Foundation
Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists.

Daegu-Gyeongbuk Medical Innovation Foundation
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.

Daegu-Gyeongbuk Medical Innovation Foundation
Design, synthesis, and evaluation of simple phenol amides as ERRγ agonists.

The Scripps Research Institute
Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents.

Janssen Research and Development
Design and synthesis of benzoacridines as estrogenic and anti-estrogenic agents.

Kyushu University
MAPK inhibitors

Everbrilliant Pharma
Intermediate compound of novel tetrahydronaphthyl urea derivative

Mochida Pharmaceutical
Heteroaryl compounds and uses thereof

Celgene Car
Inhibitors of Bruton's tyrosine kinase

Pharmacyclics
Bicyclo[3.2.1]octyl amide derivatives and uses of same

H. Lundbeck